• miDiagnostics launches its CE-IVD certified ultra-fast COVID-19 PCR test

    Monday May 2nd 2022

  • Sequana Medical announces the completion of alfapump implantations in POSEIDON, the North American pivotal alfapump study

    Tuesday April 5th 2022

  • Jyseleca® approved in Japan for ulcerative colitis

    Monday March 28th 2022

  • The fight against cancer intensified thanks to SCK CEN and the IRE

    Monday February 28th 2022

  • miDiagnostics ultra-fast COVID-19 PCR Test succeeds in Brussels Airport pilot study

    Thursday February 17th 2022

  • Medical device Morphemat® wins Gold ‘Business Innovation’ Henry van de Velde Award

    Wednesday February 9th 2022

  • UCB announces positive data in myasthenia gravis with zilucoplan phase 3 study results

    Friday February 4th 2022

  • Large UK study shows rapid EGFR testing with Idylla™ alongside NGS has potential to enhance lung cancer patient health outcomes

    Tuesday January 25th 2022

  • Your news here?

  • BIMZELX[®] (bimekizumab) approved in Japan for the treatment of plaque psoriasis, generalized pustular psoriasis and psoriatic erythroderma

    Monday January 24th 2022

  • argenx announces VYVGART™ approval in Japan for the treatment of generalized myasthenia gravis

    Friday January 21st 2022

  • argenx announces U.S. Food and Drug Administration (FDA) approval of VYVGART™ (efgartigimod alfa-fcab) in Generalized Myasthenia Gravis

    Monday December 20th 2021


Strategic Partners